Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Bob Dylan’s former, and well-preserved, Harlem home has a buyer. The landmarked Renaissance Revival townhouse at 265 W. 139th St. along Strivers’ Row served as Dylan’s home for 14 years. It recently ...

NEW YORK — In the 2016 show "Shuffle Along," subtitled "The Making of the Musical Sensation of 1921 and All That Followed," playwright and director George C. Wolfe argued that Black musical theater ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Soroosh Khodami discusses why we aren't ready ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

The earnest government disease fighter had become a kind of city archetype, alongside aspiring rappers and C-suite strivers. Now scientists are leaving. Remaking America The earnest government disease ...

‘Tax the Rich, Like Me’ reads the headline of a recent New York Times op-ed by Mitt Romney. Mr. Romney’s left-populist star turn follows the usual formula, which is along the lines of “raise the kind ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...